Industry News
Raccoon 2 SE Launches Christmas Special -- A Holiday Offer to Get Your Lawn Ready for Spring
SHENZHEN, China, Dec. 8, 2025 /PRNewswire/ -- Following its strong Kickstarter
debut, RoboUP's new-generation robot mower,the Raccoon 2 SE
2025-12-08 21:00
852
Hypershell Publishes First Consumer Exoskeleton Standards White Paper, Calling for Industry-Wide Transparency and Unified Testing Frameworks
SGS-verified performance results underscore the need for reproducible,
third-party testing across the emerging wearable robotics sector
SHENZHEN, China, Dec. 8, 2025 /PRNewswire/ -- Hypershell,
2025-12-08 21:00
946
Autocrypt Announces Product Release of Post-Quantum PKI Product, Pioneering PQC-enabled Solutions for Automotive OEMs
SEOUL, South Korea, Dec. 8, 2025 /PRNewswire/ -- Leading automotive cybersecurity solutions provider AUTOCRYPT announced onDecember 8, 2025, the launch of "AutoCrypt PKI-Vehicles," a new next-generation Public Key Infrastructure (PKI) solution supporting ML-DSA, a post-quantum digital signature ...
2025-12-08 21:00
995
Global Shift Toward Trust: 2025 Employer Branding Creativity Awards Highlight New Talent Trends
XISHUANGBANNA, China, Dec. 8, 2025 /PRNewswire/ -- As global competition for talent intensifies, organisations are increasingly elevating employer branding from a recruitment-focused activity to a core strategic capability. Authentic storytelling, employee-experience design and trust-building hav...
2025-12-08 20:00
935
HanchorBio Presents First-in-Human Data of HCB101 Monotherapy in Relapsed/Refractory Non-Hodgkin Lymphoma at ASH 2025
Early Phase 1 monotherapy data demonstrate cytopenia-sparing safety, broad pharmacologic window, and early clinical activity in relapsed/refractory non-Hodgkin lymphoma (NHL) TAIPEI, SHANGHAI, and SAN FRANCISCO, Dec. 8, 2025 /PRNewswire/ -- HanchorBio Inc. (TPEx: 7827), a global clinical-stage b...
2025-12-08 20:00
1145
51Talk Online Education Group Announces New Share Repurchase Program
SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk", or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, today announced that its board of directors has authorized a new share repurchase program under whi...
2025-12-08 19:35
2125
Huya Announces January 7, 2026 Open Beta Launch for Goose Goose Duck Mobile in Chinese Mainland
GUANGZHOU, China, Dec. 8, 2025 /PRNewswire/ -- HUYA Inc. ("Huya" or the "Company") (NYSE: HUYA), a leading game-related entertainment and services provider, today announced that the popular social deduction gameGoose Goose Duck mobile, co‑published by Huya and Kingsoft Shiyou in the Chinese mainl...
2025-12-08 19:30
1042
51Talk Online Education Group Announces Third Quarter 2025 Results
SINGAPORE, Dec. 8, 2025 /PRNewswire/ -- 51Talk Online Education Group ("51Talk" or the "Company") (NYSE American: COE), a global online education platform with core expertise in English education, announced its unaudited results for the third quarter endedSeptember 30, 2025. Third Quarter 2025 F...
2025-12-08 19:30
3503
Geleximco Group and China intelligent chassis solution provider Leekr Technology signed a MoU to deepen industrial collaboration
SHANGHAI, Dec. 8, 2025 /PRNewswire/ -- Geleximco Group and Leekr Technology, a leading Chinese provider of intelligent chassis system solutions, formally signed a Memorandum of Understanding (MoU) inShanghai. By combining their respective strengths, the two companies will deepen industrial cooper...
2025-12-08 18:03
1027
Sennics Unveils Major Breakthroughs in New Eco-Friendly Antioxidant SA6000
SHANGHAI, Dec. 8, 2025 /PRNewswire/ -- On December 8, 2025, to commemorate the second anniversary of the Seminar on Future Development Trends in Rubber Additives, Sennics showcased its research achievements from the past two years, highlighting significant progress in developing its novel eco-fri...
2025-12-08 17:01
901
SJTU International Gen Z Students Explore Shanghai's Innovation Ecosystem
SHANGHAI, Dec. 8, 2025 /PRNewswire/ -- Shanghai Jiao Tong University's Antai Global Summer Program (AGSP) welcomed a diverse cohort of over 80 Gen Z students from 28 leading universities across 22 countries for an immersive exploration ofShanghai's world-class innovation ecosystem (July 9-24). Th...
2025-12-08 16:57
871
Yantai offers global bay areas a paradigm of low-carbon transformation
YANTAI, China, Dec. 8, 2025 /PRNewswire/ -- On December 4, the 2025 Shandong Green Low-carbon High-quality Development Conference was held in Yantai,Shandong province. Against the backdrop of the fifth anniversary ofChina's 'dual carbon' goals, Yantai's achievements—as one of the country's first ...
2025-12-08 16:52
1000
GC Biopharma Ships First Doses of World's First Recombinant Anthrax Vaccine, 'BARYTHRAX inj.'
- First anthrax vaccine developed using recombinant DNA technology - Annual production capacity of up to 10 million doses at GC Biopharma's facility YONGIN, South Korea, Dec. 8, 2025 /PRNewswire/ -- GC Biopharma (006280.KS), a leading global biopharmaceutical company, today announced the first sh...
2025-12-08 14:36
1090
CIMC Unveils New Global Brand Logo and Visual Identity System
SHENZHEN, China, Dec. 7, 2025 /PRNewswire/ -- On December 5, 2025, China International Marine Containers (Group) Co., Ltd. (CIMC) unveiled its new brand logo and visual identity system to a global audience. Marking the company's most significant brand upgrade in nearly fifteen years, the launch s...
2025-12-08 10:21
1108
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...
2025-12-08 10:08
1760
Median PFS Trending Beyond One Year: Leads Biolabs' LBL-034 Showcases Breakthrough Clinical Data in Oral Presentation at the 2025 ASH Annual Meeting
NANJING, China, Dec. 7, 2025 /PRNewswire/ -- From December 6 to 9, 2025, the 67th Annual Meeting of the American Society of Hematology ("ASH") was held in Orlando, Florida, USA. Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company", Stock Code: 9887.HK) delivered an oral presentation o...
2025-12-08 10:00
1012
IASO Bio Presents Updated Results for Equecabtagene Autoleucel in High-Risk Newly Diagnosed Multiple Myeloma Patients at 2025 ASH
SHANGHAI and NANJING, China and PLEASANTON, Calif., Dec. 7, 2025 /PRNewswire/ -- IASO Biotechnology ("IASO Bio"), a commercial-stage biopharmaceuticalcompany focused on the discovery, development, manufacturing, and commercialization of novel cell therapies and biologics for hematologic malignanc...
2025-12-08 09:57
897
ASH 2025 Oral Presentation: Innovent Biologics Announces Initial Results of the First-in-Human Phase 1 Study of Trispecific Antibody IBI3003 in Relapsed or Refractory Multiple Myeloma
SAN FRANCISCO and SUZHOU, China, Dec. 7, 2025 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic...
2025-12-08 09:02
1212
Global Times: Mogao Caves' mural paintings meet modern technology
BEIJING, Dec. 7, 2025 /PRNewswire/ -- The flying Apsaras dance across the heavens; caravan bells echo along ancient routes. Dunhuang, a pivotal hub on the ancient Silk Road, served as a crossroads where diverse civilizations converged, giving birth to the radiant splendor of the Mogao Caves. As a...
2025-12-08 08:48
841
CARsgen Announces Data of Allogeneic BCMA CAR-T Cell Therapy CT0596 for Relapsed/Refractory Multiple Myeloma at the 2025 ASH Annual Meeting
SHANGHAI, Dec. 7, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that clinical data from its allogeneic BCMA-targeted CAR T-cell product candidate, CT0596, for the treatment of relapsed/r...
2025-12-08 08:15
1187
Week's Top Stories
Most Reposted
Visa Supports Chinese Cardholders to Add Cards to Apple Pay for a More Convenient and Secure Payment Experience
[Picked up by 310 media titles]
2026-01-15 13:00AVPN's AI Opportunity Fund Expands Regional Efforts to Build AI Skilling Infrastructure for a Future-Ready Workforce Across Asia-Pacific
[Picked up by 300 media titles]
2026-01-21 12:39JIOS Aerogel® Secures Hyundai Contract Through New Licensing Model
[Picked up by 296 media titles]
2026-01-15 10:00Infobip strengthens leadership to drive growth and innovation
[Picked up by 281 media titles]
2026-01-16 11:00
Klook's study of 374,000 reviews finds that lesser-known cities create deeper emotional connection with travelers
[Picked up by 279 media titles]
2026-01-20 15:40
